Skip to content

Ofri Mosenzon

    • 27h-indexImpact measure calculated using publication and citation counts. Updated daily.
    • 6000CitationsNumber of citations received by Ofri's publications. Updated daily.

    Recent publications

    • Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

      • Bentley-Lewis R
      • Aguilar D
      • Riddle M
      • et al.
    • Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

      • De Zeeuw D
      • Akizawa T
      • Audhya P
      • et al.

    Co-authors (3983)

    Other IDs